Blog

High-quality HIV biospecimens are essential for developing and validating accurate diagnostic assays. A recent peer-reviewed study published in the Journal of Clinical Virology Plus demonstrated excellent analytical and clinical agreement for the Siemens Healthineers HIV Antigen/Antibody Combo assay across multiple automated testing platforms. The study utilized well-characterized HIV-positive and HIV-negative serum specimens, including samples sourced […]

July 14, 2026

Clinical trial success depends on more than patient recruitment. Learn why high-quality clinical data, biospecimen integrity, and operational excellence are becoming critical competitive advantages in modern clinical research.

June 18, 2026

Selecting the right biospecimen and lab testing services partner is critical for generating reliable data, accelerating timelines, and supporting regulatory success. This blog outlines seven key factors pharma and IVD teams should evaluate, including biospecimen access, CLIA-certified testing, biomarker expertise, regulatory experience, data traceability, and integrated laboratory services. Learn how the right partner can help […]

May 19, 2026

Learn how Boca Bio helped a next-generation drug discovery company complete a chronic migraine biomarker study within two months through high-quality biospecimen collection, multi-site patient recruitment, and precise sample handling that preserved biomarker integrity.

May 19, 2026

A global diagnostics company accelerated FDA approval and market launch for 12 infectious disease tests by partnering with Boca Bio. Facing delays from slow, inflexible vendors, the company needed rapid sample sourcing, faster testing, and agile clinical support. Boca Bio delivered results up to 12x faster, reduced site activation timelines by half, and ensured compliance […]

April 28, 2026